{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:52:54Z","timestamp":1792183974111,"version":"4.4.0"},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>Lambert-Eaton myasthenic syndrome (LEMS) is an immune-mediated disorder of the presynaptic neuromuscular transmission, which more frequently occurs as the remote effect of a neoplasm, in the paraneoplastic form (P-LEMS), or in a non-paraneoplastic form (NP-LEMS); but few studies describe the clinical features of NP-LEMS. We analyzed the clinical manifestations, laboratory findings, electrophysiological studies, and treatment responses in ten Brazilian patients suffering from NP-LEMS. The mean age was 41.5 years. More often neurological findings were hyporeflexia or areflexia with a post-exercise improvement. Treatment response occurred with pyridostigmine, guanidine, prednisone, azathioprine, and cyclosporine; but not response was observed after intravenous immunoglobulin and plasma exchange. Age at onset, clinical manifestations, and electrophysiological abnormalities can help more in the diagnosis than serum antibodies; the symptomatic treatment with pyridostigmine was effective; and the immunosuppressive treatment with prednisone, azathioprine, or cyclosporine was more beneficial than plasma exchange or intravenous immunoglobulin treatment.<\/jats:p>","DOI":"10.1590\/s0004-282x2010000600004","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T19:13:47Z","timestamp":1298574827000},"page":"849-854","source":"Crossref","is-referenced-by-count":16,"title":["Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases"],"prefix":"10.1590","volume":"68","author":[{"given":"Paulo J.","family":"Lorenzoni","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana H.","family":"Scola","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia S. Kamoi","family":"Kay","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio F.","family":"Parolin","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lineu C.","family":"Werneck","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0733-8619(05)70336-4","article-title":"Paraneoplastic neuromuscular syndromes","volume":"15","author":"Levin KH","year":"1997","journal-title":"Neurol Clin","ISSN":"https:\/\/id.crossref.org\/issn\/0733-8619","issn-type":"print"},{"key":"ref2","first-page":"181","article-title":"Neuromuscular junction channelopathies: a brief overview","volume":"105","author":"Newsom-Davis J","year":"2005","journal-title":"Acta Neurol Belg","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9009","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/S0004-282X1998000300017","article-title":"Lambert-Eaton myasthenic syndrome: report of two cases","volume":"56","author":"Scola RH","year":"1998","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/jnnp.70.2.212","article-title":"Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer","volume":"70","author":"Maddison P","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref5","first-page":"1237","article-title":"The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases","volume":"39","author":"Motomura M","year":"1999","journal-title":"Rinsho Shinkeigatu"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","article-title":"Seronegative Lambert-Eaton myasthenic syndrome: study of 110 japanese patients","volume":"59","author":"Nakao YK","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.05.025","article-title":"The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients","volume":"201-202","author":"Titulaer MJ","year":"2008","journal-title":"J Neuroimmunol","ISSN":"https:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0303-8467(02)00054-9","article-title":"Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases","volume":"104","author":"Wirtz PW","year":"2002","journal-title":"Clin Neurol Neurosurg","ISSN":"https:\/\/id.crossref.org\/issn\/0303-8467","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome: a review of 50 cases","volume":"111","author":"O'Neill JH","year":"1988","journal-title":"Brain","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8950","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/mus.1140","article-title":"Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome","volume":"24","year":"2001","journal-title":"Muscle Nerve","ISSN":"https:\/\/id.crossref.org\/issn\/0148-639X","issn-type":"print"},{"key":"ref11","series-title":"Electrodiagnostic medicine","first-page":"1149","volume-title":"Neuromuscular junction disorders","author":"Amato AA","year":"2002","edition":"2nd"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jns.2008.02.004","article-title":"Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"270","author":"Lorenzoni PJ","year":"2008","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref13","first-page":"198","article-title":"Myasthenia gravis with electrographic findings of myasthenic syndrome: a case report","volume":"43","author":"Werneck LC","year":"1985","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2009.09.017","article-title":"Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients","volume":"217","author":"Pellkofer HL","year":"2009","journal-title":"J Neuroimmunol","ISSN":"https:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11940-009-0010-z","article-title":"Lambert-Eaton myasthenic syndrome","volume":"11","author":"Weimer MB","year":"2009","journal-title":"Curr Treat Opt Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","article-title":"Guidelines for the treatment of autoimmune neuromuscular transmission disorders","volume":"13","author":"Skeie GO","year":"2006","journal-title":"Eur J Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/1351-5101","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/14656566.7.10.1323","article-title":"Available treatment options for the management of Lambert-Eaton myasthenic syndrome","volume":"7","author":"Verschuuren JJGM","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.54.11.2176","article-title":"Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment","volume":"54","author":"Tim RW","year":"2000","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v68n6\/04.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T18:32:04Z","timestamp":1495823524000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2010000600004&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0004-282X2010000600004"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2010000600004","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}